At the news
? NEUTRALIMPACT 5/10 DEFA14A filed Jul 8, 2026 at 21:53 ET
IREN's independent chair issued a letter to shareholders defending the board's decision to grant approximately 3% RSU stakes (each) to co-CEOs Dan and Will Roberts, totaling ~6% potential dilution. The awards vest over four years with a two-year post-vesting lockup, and no further equity grants are planned until FY2031. The board argues the grants are necessary to retain the founders after the company's market cap grew from under $4B to over $16B and key customer wins (NVIDIA, Microsoft).
- Each Founder-CEO received RSUs representing approximately 3% of the company (combined ~6% total dilution).
- Awards vest in four equal annual tranches with a two-year post-vesting lockup; final tranche sale-blocked until FY2033.
- No further equity grants to the CEO-pair until the company's 2031 fiscal year.
- The board granted the 2026 Award (July 1, 2026) after demonstrated performance, following a smaller 2025 Award.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access